The INK4A/ARF locus and its two gene products.

p53, the cellular gatekeeper for growth and division

Levine, A. J. (1997) · Cell · doi:10.1016/s0092-8674(00)81871-1 · Cited by 7,693 · see citing works

Cancer Cell Cycles

Sherr, C. J. (1996) · Science · doi:10.1126/science.274.5293.1672 · Cited by 5,379 · see citing works

Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a

Serrano, M., Lin, A. W., McCurrach, M. E., Beach, D., & Lowe, S. W. (1997) · Cell · doi:10.1016/s0092-8674(00)81902-9 · Cited by 5,178 · see citing works

Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours

Donehower, L. A., Harvey, M., Slagle, B. L., McArthur, M. J., Montgomery, C. A., Butel, J. S., & Bradley, A. (1992) · Nature · doi:10.1038/356215a0 · Cited by 4,649 · see citing works

Mdm2 promotes the rapid degradation of p53

Haupt, Y., Maya, R., Kazaz, A., & Oren, M. (1997) · Nature · doi:10.1038/387296a0 · Cited by 4,506 · see citing works

A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4.

Serrano, M., Hannon, G. J., & Beach, D. (1993) · Nature · doi:10.1038/366704a0 · Cited by 3,650 · see citing works

Regulation of p53 stability by Mdm2

Kubbutat, M. H. G., Jones, S. N., & Vousden, K. H. (1997) · Nature · doi:10.1038/387299a0 · Cited by 3,312 · see citing works

Induction of apoptosis in fibroblasts by c-myc protein

Evan, G. I., Wyllie, A. H., Gilbert, C. S., Littlewood, T. D., Land, H., Brooks, M. W., Waters, C. M., Penn, L. Z., & Hancock, D. C. (1992) · Cell · doi:10.1016/0092-8674(92)90123-t · Cited by 2,941 · see citing works

Tumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes

Land, H., Parada, L. F., & Weinberg, R. A. (1983) · Nature · doi:10.1038/304596a0 · Cited by 2,804 · see citing works

A cell cycle regulator potentially involved in genesis of many tumor types

Kamb, A., Gruis, N. A., Weaver-Feldhaus, J., Liu, Q., Harshman, K., Tavtigian, S. V., Stockert, E., Day, R. S., Johnson, B. E., & Skolnick, M. H. (1994) · Science · doi:10.1126/science.8153634 · Cited by 2,751 · see citing works

Activation of p53 Sequence-Specific DNA Binding by Acetylation of the p53 C-Terminal Domain

Gu, W., & Roeder, R. G. (1997) · Cell · doi:10.1016/s0092-8674(00)80521-8 · Cited by 2,559 · see citing works

The regulation of E2F by pRB-family proteins.

Dyson, N. (1998) · Genes & Development · doi:10.1101/gad.12.15.2245 · Cited by 2,317 · see citing works

Tumor spectrum analysis in p53-mutant mice

Jacks, T., Remington, L., Williams, B. O., Schmitt, E. M., Halachmi, S., Bronson, R. T., & Weinberg, R. A. (1994) · Current Biology · doi:10.1016/s0960-9822(00)00002-6 · Cited by 2,051 · see citing works

pl5INK4B is a potentia| effector of TGF-β-induced cell cycle arrest

Hannon, G. J., & Beach, D. (1994) · Nature · doi:10.1038/371257a0 · Cited by 1,950 · see citing works

ARF promotes MDM2 degradation and stabilizes p53: ARF-INK4a locus deletion impairs both the Rb and p53 tumor suppression pathways

Zhang, Y., Xiong, Y., & Yarbrough, W. G. (1998) · Cell · doi:10.1016/s0092-8674(00)81401-4 · Cited by 1,626 · see citing works

Role of the INK4a Locus in Tumor Suppression and Cell Mortality

Serrano, M., Lee, H.-W., Chin, L., Cordon-Cardo, C., Beach, D., & DePinho, R. A. (1996) · Cell · doi:10.1016/s0092-8674(00)81079-x · Cited by 1,585 · see citing works

The oncogene and Polycomb-group gene bmi-1 regulates cell proliferation and senescence through the ink4a locus

Jacobs, J. J. L., Kieboom, K., Marino, S., DePinho, R. A., & van Lohuizen, M. (1999) · Nature · doi:10.1038/16476 · Cited by 1,580 · see citing works

Tumor Suppression at the Mouse INK4a Locus Mediated by the Alternative Reading Frame Product p19

Kamijo, T., Zindy, F., Roussel, M. F., Quelle, D. E., Downing, J. R., Ashmun, R. A., Grosveld, G., & Sherr, C. J. (1997) · Cell · doi:10.1016/s0092-8674(00)80452-3 · Cited by 1,566 · see citing works

The Ink4a tumor suppressor gene product, p19Arf, interacts with MDM2 and neutralizes MDM2’s inhibition of p53

Pomerantz, J., Schreiber-Agus, N., Liégeois, N. J., Silverman, A., Alland, L., Chin, L., Potes, J., Chen, K., Orlow, I., Lee, H.-W., et al. (1998) · Cell · doi:10.1016/s0092-8674(00)81400-2 · Cited by 1,521 · see citing works

Alternative reading frames of the INK4a tumor suppressor gene encode two unrelated proteins capable of inducing cell cycle arrest

Ouelle, D. E., Zindy, F., Ashmun, R. A., & Sherr, C. J. (1995) · Cell · doi:10.1016/0092-8674(95)90214-7 · Cited by 1,485 · see citing works

Germline p16 mutations in familial melanoma

Hussussian, C. J., Struewing, J. P., Goldstein, A. M., Higgins, P., Ally, D. S., Sheahan, M. D., Clark, W. H., Tucker, M. A., & Dracopoli, N. C. (1994) · Nature Genetics · doi:10.1038/ng0994-15 · Cited by 1,252 · see citing works

Myc signaling via the ARF tumor suppressor regulates p53-dependent apoptosis and immortalization

Zindy, F., Eischen, C. M., Randle, D. H., Kamijo, T., Cleveland, J. L., Sherr, C. J., & Roussel, M. F. (1998) · Genes & Development · doi:10.1101/gad.12.15.2424 · Cited by 1,245 · see citing works

The alternative product from the human CDKN2A locus, p14ARF, participates in a regulatory feedback loop with p53 and MDM2

Stott, F. J., Bates, S., James, M. C., McConnell, B. B., Starborg, M., Brookes, S., Palmero, I., Ryan, K. M., Hara, E., Vousden, K. H., et al. (1998) · The EMBO Journal · doi:10.1093/emboj/17.17.5001 · Cited by 1,165 · see citing works

A p16 INK4a -Insensitive CDK4 Mutant Targeted by Cytolytic T Lymphocytes in a Human Melanoma

Wölfel, T., Hauer, M., Schneider, J., Serrano, M., Wölfel, C., Klehmann, E., Plaen, E. D., Hankeln, T., Büschenfelde, K. M. Z., & Beach, D. (1995) · Science · doi:10.1126/science.7652577 · Cited by 1,153 · see citing works

Frequent somatic mutations and homozygous deletions of the p16 (MTS1) gene in pancreatic adenocarcinoma

Caldas, C., Hahn, S. A., da Costa, L. T., Redston, M. S., Schutte, M. E. M., Seymour, A. B., Weinstein, C. L., Hruban, R. H., Yeo, C. J., & Kern, S. E. (1994) · Nature Genetics · doi:10.1038/ng0994-27 · Cited by 1,132 · see citing works

Premature senescence involving p53 and p16 is activated in response to constitutive MEK/MAPK mitogenic signaling

Lin, A. W., Barradas, M., Stone, J. C., van Aelst, L., Serrano, M., & Lowe, S. W. (1998) · Genes & Development · doi:10.1101/gad.12.19.3008 · Cited by 945 · see citing works

p14ARF links the tumour suppressors RB and p53

Bates, S., Phillips, A. C., Clark, P. A., Stott, F., Peters, G., Ludwig, R. L., & Vousden, K. H. (1998) · Nature · doi:10.1038/25867 · Cited by 918 · see citing works

Functional and physical interactions of the ARF tumor suppressor with p53 and Mdm2

Kamijo, T., Weber, J. D., Zambetti, G., Zindy, F., Roussel, M. F., & Sherr, C. J. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.14.8292 · Cited by 899 · see citing works

Constitutive c-myc expression in an IL-3-dependent myeloid cell line suppresses cell cycle arrest and accelerates apoptosis.

Askew, D. S., Ashmun, R. A., Simmons, B. C., & Cleveland, J. L. (1991) · PubMed · Cited by 867 · see citing works

Analysis of the p16 gene (CDKN2) as a candidate for the chromosome 9p melanoma susceptibility locus

Kamb, A., Shattuck-Eidens, D. M., Eeles, R. A., Liu, Q., Gruis, N. A., Ding, W., Hussey, C. E., Tran, T., Miki, Y., Weaver-Feldhaus, J., et al. (1994) · Nature Genetics · doi:10.1038/ng0994-22 · Cited by 855 · see citing works

p53 and E2F-1 cooperate to mediate apoptosis.

Wu, X., & Levine, A. J. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.9.3602 · Cited by 836 · see citing works

Senescence of human fibroblasts induced by oncogenic Raf

Zhu, J., Woods, D., McMahon, M., & Bishop, J. M. (1998) · Genes & Development · doi:10.1101/gad.12.19.2997 · Cited by 826 · see citing works

Germline mutations in the p16INK4a binding domain of CDK4 in familial melanoma

Zuo, L., Weger, J., Yang, Q., Goldstein, A. M., Tucker, M. A., Walker, G. J., Hayward, N., & Dracopoli, N. C. (1996) · Nature Genetics · doi:10.1038/ng0196-97 · Cited by 818 · see citing works

Deregulated transcription factor E2F-1 expression leads to S-phase entry and p53-mediated apoptosis.

Qin, X. Q., Livingston, D. M., Kaelin, W. G., & Adams, P. D. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.23.10918 · Cited by 753 · see citing works

Tumor surveillance via the ARF–p53 pathwayPreprint

Sherr, C. J. (1998) · Genes & Development · doi:10.1101/gad.12.19.2984 · Cited by 716 · see citing works

Growth suppression by p18, a p16INK4/MTS1- and p14INK4B/MTS2-related CDK6 inhibitor, correlates with wild-type pRb function.Preprint

Guan, K., Jenkins, C. W., Li, Y., Nichols, M. A., Wu, X., O'Keefe, C., Matera, A. G., & Xiong, Y. (1994) · Genes & Development · doi:10.1101/gad.8.24.2939 · Cited by 707 · see citing works

Binding and modulation of p53 by p300/CBP coactivators

Lill, N. L., Grossman, S. R., Ginsberg, D., DeCaprio, J. A., & Livingston, D. M. (1997) · Nature · doi:10.1038/42981 · Cited by 693 · see citing works

Tumor-suppressive pathways in pancreatic carcinoma.

Rozenblum, E., Schutte, M. E. M., Goggins, M., Hahn, S. A., Panzer, S., ZAHURAK, M. L., Goodman, S. N., Sohn, T. A., Hruban, R. H., Yeo, C. J., et al. (1997) · PubMed · Cited by 693 · see citing works

Recruitment of p300/CBP in p53-Dependent Signal Pathways

Avantaggiati, M. L., Ogryzko, V. V., Gardner, K., Giordano, A., Levine, A. S., & Kelly, K. (1997) · Cell · doi:10.1016/s0092-8674(00)80304-9 · Cited by 668 · see citing works

Stabilization of the p53 tumor suppressor is induced by adenovirus 5 E1A and accompanies apoptosis.Preprint

Lowe, S. W., & Ruley, H. E. (1993) · Genes & Development · doi:10.1101/gad.7.4.535 · Cited by 662 · see citing works

The adenovirus E1A proteins induce apoptosis, which is inhibited by the E1B 19-kDa and Bcl-2 proteins.

Rao, L., Debbas, M. E., Sabbatini, P., Hockenbery, D. M., Korsmeyer, S. J., & White, E. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.16.7742 · Cited by 660 · see citing works

Increased Risk of Pancreatic Cancer in Melanoma-Prone Kindreds withp16INK4Mutations

Goldstein, A. M., Fraser, M. C., Struewing, J. P., Hussussian, C. J., Ranade, K., Zametkin, D. P., Fontaine, L. S., Organic, S. M., Dracopoli, N. C., Clark, W. H., et al. (1995) · New England Journal of Medicine · doi:10.1056/nejm199510123331504 · Cited by 620 · see citing works

p19ARF links the tumour suppressor p53 to Ras

Palmero, I., Pantoja, C., & Serrano, M. (1998) · Nature · doi:10.1038/25870 · Cited by 617 · see citing works

p53-dependent apoptosis produced by Rb-deficiency in the developing mouse lens

Morgenbesser, S. D., Williams, B. O., Jacks, T., & DePinho, R. A. (1994) · Nature · doi:10.1038/371072a0 · Cited by 607 · see citing works

E1A signaling to p53 involves the p19ARFtumor suppressorPreprint

de Stanchina, E., McCurrach, M. E., Zindy, F., Shieh, S.-Y., Ferbeyre, G., Samuelson, A. V., Prives, C. L., Roussel, M. F., Sherr, C. J., & Lowe, S. W. (1998) · Genes & Development · doi:10.1101/gad.12.15.2434 · Cited by 607 · see citing works

Synergistic activation of transcription by CBP and p53

Gu, W., Shi, X.-L., & Roeder, R. G. (1997) · Nature · doi:10.1038/42972 · Cited by 596 · see citing works

Mutations and altered expression of p16INK4 in human cancer.

Okamoto, A., Demetrick, D. J., Spillare, E. A., Hagiwara, K., Hussain, S. P., Bennett, W. P., Forrester, K., Gerwin, B. I., Serrano, M., & Beach, D. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.23.11045 · Cited by 541 · see citing works

Deregulated Expression of E2F-1 Induces S-Phase Entry and Leads to Apoptosis

Shan, B., & Lee, W. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.12.8166 · Cited by 529 · see citing works

Structural basis for inhibition of the cyclin-dependent kinase Cdk6 by the tumour suppressor p16INK4a

Russo, A. A., Tong, L., Lee, J.-O., Jeffrey, P. D., & Pavletich, N. P. (1998) · Nature · doi:10.1038/26155 · Cited by 524 · see citing works

Tumour-derived p16 alleles encoding proteins defective in cell-cycle inhibition

Koh, J., Enders, G. H., David Dynlacht, B., & Harlow, E. (1995) · Nature · doi:10.1038/375506a0 · Cited by 516 · see citing works

Review of alterations of the cyclin-dependent kinase inhibitor INK4 family genes p15, p16, p18 and p19 in human leukemia–lymphoma cells

Drexler, H. (1998) · Leukemia · doi:10.1038/sj.leu.2401043 · Cited by 430 · see citing works

p300/MDM2 complexes participate in MDM2-mediated p53 degradation

Grossman, S. R., Perez, M., Kung, A. L., Joseph, M., Mansur, C., Xiao, Z.-X., Kumar, S., Howley, P. M., & Livingston, D. M. (1998) · Molecular Cell · doi:10.1016/s1097-2765(00)80140-9 · Cited by 414 · see citing works

Complex structure and regulation of the P16 (MTS1) locus.

Stone, S., Jiang, P., Dayananth, P., Tavtigian, S. V., Katcher, H. L., Parry, D., Peters, G., & Kamb, A. (1995) · PubMed · Cited by 383 · see citing works

Inhibition of Ras-Induced Proliferation and Cellular Transformation by p16 INK4

Serrano, M., Gómez-Lahoz, E., DePinho, R. A., Beach, D., & Bar‐Sagi, D. (1995) · Science · doi:10.1126/science.7809631 · Cited by 373 · see citing works

A novel p16INK4A transcript.

Mao, L., Merlo, A. U., Bedi, G. C., Shapiro, G. I., Edwards, C. D., Rollins, B. J., & Sidransky, D. (1995) · PubMed · Cited by 329 · see citing works

Homozygotes for CDKN2 (p16) germline mutation in Dutch familial melanoma kindreds

Gruis, N. A., van der Velden, P. A., Sandkuijl, L. A., Prins, D. E. M., Weaver-Feldhaus, J., Kamb, A., Bergman, W., & Frants, R. R. (1995) · Nature Genetics · doi:10.1038/ng0795-351 · Cited by 309 · see citing works

A Familial Syndrome of Pancreatic Cancer and Melanoma with a Mutation in theCDKN2Tumor-Suppressor Gene

Whelan, A. J., Bartsch, D. K., & Goodfellow, P. J. (1995) · New England Journal of Medicine · doi:10.1056/nejm199510123331505 · Cited by 280 · see citing works

CDKN2AMutations in Multiple Primary Melanomas

Monzon, J. G., Liu, L., Brill, H., Goldstein, A. M., Tucker, M. A., From, L., McLaughlin, J. R., Hogg, D., & Lassam, N. J. (1998) · New England Journal of Medicine · doi:10.1056/nejm199803263381305 · Cited by 262 · see citing works

Mutation and altered expression of p16^ in human cancer

Okamoto, A. (1994) · Proceedings of the National Academy of Sciences · Cited by 234 · see citing works

Angiogenesis as an unfavorable prognostic factor in human colorectal carcinoma

Takebayashi, Y., Akiyama, S., Yamada, K., Akiba, S., & Aikou, T. (1996) · Cancer · doi:10.1002/(sici)1097-0142(19960715)78:2 · Cited by 222 · see citing works

Cancer-associated mutations at the INK4a locus cancel cell cycle arrest by p16 INK4a but not by the alternative reading frame protein p19 ARF

Quelle, D. E., Cheng, M. M., Ashmun, R. A., & Sherr, C. J. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.2.669 · Cited by 217 · see citing works

A functionally inactive p53 protein interatocarcinoma cells is activated by either DNA damage or cellular differentiation

Lutzker, S. G., & Levine, A. J. (1996) · Nature Medicine · doi:10.1038/nm0796-804 · Cited by 206 · see citing works

Prevalence of germ-line mutations in p16, p19ARF, and CDK4 in familial melanoma: analysis of a clinic-based population.

FitzGerald, M. G., Harkin, D. P., Silva-Arrieta, S., MacDonald, D. J., Lucchina, L. C., Ünsal, H., O'Neill, E., Koh, J., Finkelstein, D. M., Isselbacher, K. J., et al. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.16.8541 · Cited by 199 · see citing works

CREB-binding protein and p300/CBP-associated factor are transcriptional coactivators of the p53 tumor suppressor protein.

Scolnick, D. M., Chehab, N. H., Stavridi, E. S., Lien, M. C., Caruso, L. C., Morán, E., Berger, S. L., & Halazonetis, T. D. (1997) · PubMed · Cited by 186 · see citing works

p16 ^<i>INK4A</i> Participates in a G ₁ Arrest Checkpoint in Response to DNA Damage

Shapiro, G. I., Edwards, C. D., Ewen, M. E., & Rollins, B. J. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.1.378 · Cited by 165 · see citing works

Molecular genetics of familial cutaneous melanoma.

Haluska, F. G., & Hodi, F. S. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.2.670 · Cited by 154 · see citing works

Among genes involved in the RB dependent cell cycle regulatory cascade, the p16 tumor suppressor gene is frequently lost in the Ewing family of tumors

Kovar, H., Jug, G., Aryee, D. N. T., Zoubek, A., Ambros, P. F., Gruber, B., Windhager, R. H., & Gadner, H. (1997) · Oncogene · doi:10.1038/sj.onc.1201397 · Cited by 149 · see citing works

p19 Arf induces p53-dependent apoptosis during Abelson virus-mediated pre-B cell transformation

Radfar, A., Unnikrishnan, I., Lee, H., DePinho, R. A., & Rosenberg, N. E. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.22.13194 · Cited by 138 · see citing works

Loss of the p16INK4a and p15INK4b genes, as well as neighboring 9p21 markers, in sporadic melanoma.

Flores, J. F., Walker, G. J., Glendening, J. M., Haluska, F. G., Castresana, J. S., Rubio, M., Pastorfide, G. C., Boyer, L. A., Kao, W. H., Bulyk, M. L., et al. (1996) · PubMed · Cited by 136 · see citing works

A new type of p16INK4/MTS1 gene transcript expressed in B-cell malignancies.

Duro, D., Bernard, O., Della-Valle, V., Berger, R., & Larsen, C. (1995) · PubMed · Cited by 130 · see citing works

Inactivation of multiple tumor-suppressor genes involved in negative regulation of the cell cycle, MTS1/p16INK4A/CDKN2, MTS2/p15INK4B, p53, and Rb genes in primary lymphoid malignancies

Hangaishi, A., Ogawa, S., Imamura, N., Miyawaki, S., Miura, Y., Uike, N., Shimazaki, C., Emi, N., Takeyama, K., Hirosawa, S., et al. (1996) · Blood · doi:10.1182/blood.v87.12.4949.bloodjournal87124949 · Cited by 115 · see citing works

Genetic evidence in melanoma and bladder cancers that p16 and p53 function in separate pathways of tumor suppression.

Gruis, N. A., Weaver-Feldhaus, J., Liu, Q., Frye, C., Eeles, R. A., Orlow, I., Lacombe, L., Ponce-Castañeda, V., LIANES, P., & Latres, E. (1995) · Europe PMC (PubMed Central) · Cited by 113 · see citing works

Genomic Alterations of the p19ARF Encoding Exons in T-Cell Acute Lymphoblastic Leukemia

Gardie, B., Cayuela, J., Martini, S., & Sigaux, F. (1998) · Blood · doi:10.1182/blood.v91.3.1016 · Cited by 106 · see citing works

Analysis of the p16 gene, CDKN2, in 17 Australian melanoma kindreds.

Holland, E. A., Beaton, S. C., Becker, T. M., Grulet, O., Peters, B. A., Rizos, H., Kefford, R. F., & Mann, G. J. (1995) · PubMed · Cited by 101 · see citing works

Alterations of the p16 gene in head and neck cancer: frequency and association with p53, PRAD-1 and HPV

Olshan, A. F., Weissler, M. C., Pei, H., Conway, K., Anderson, S. P., Fried, D. B., & Yarbrough, W. G. (1997) · Oncogene · doi:10.1038/sj.onc.1200892 · Cited by 85 · see citing works

Analysis of the CDKN2A, CDKN2B and CDK4 genes in 48 Australian melanoma kindreds

Flores, J. F., Pollock, P. M., Walker, G. J., Glendening, J. M., Lin, A. H.-T., Palmer, J. M., Walters, M. K., Hayward, N. K., & Fountain, J. W. (1997) · Oncogene · doi:10.1038/sj.onc.1201470 · Cited by 84 · see citing works

Mutations and polymorphisms in thep53, p21 andp16 genes in oral carcinomas of Indian betel quid chewers

Heinzel, P. A., Balaram, P., & Bernard, H. (1996) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19961115)68:4 · Cited by 70 · see citing works

Homozygous loss of the p15INK4B gene (and not the p16INK4 gene) during tumor progression in a sporadic melanoma patient.

Glendening, J. M., Flores, J. F., Walker, G. J., Stone, S., Albino, A. P., & Fountain, J. W. (1995) · PubMed · Cited by 57 · see citing works

Analysis of the p16INK4 and TP53 tumor suppressor genes in bone sarcoma pediatric patients

Patiño‐García, A., & Sierrasesúmaga, L. (1997) · Cancer Genetics and Cytogenetics · doi:10.1016/s0165-4608(96)00397-4 · Cited by 42 · see citing works

Analysis of p53, p16MTS1, p21WAF1 and H-ras in archived bladder tumours from workers exposed to aromatic amines

Sørlie, T., Martel‐Planche, G., Hainaut, P. L., Lewalter, J., Holm, R., Børresen-Dale, A.-L., & Montesano, R. (1998) · British Journal of Cancer · doi:10.1038/bjc.1998.259 · Cited by 32 · see citing works

Alterations of multiple tumor suppressor genes (p53 (17p13), p16INK4 (9p21), and DBM (13q14)) in B‐CELL chronic lymphocytic leukemia

Newcomb, E. W., Rao, L. S., Giknavorian, S. S., & Lee, S. Y. (1995) · Molecular Carcinogenesis · doi:10.1002/mc.2940140302 · Cited by 21 · see citing works

Coincidental alterations of p16INK4A/CDKN2 and other genes in human lung cancer cell lines.

藤下, 隆., Mizushima, Y., Kashii, T., & Kobayashi, M. (1998) · PubMed · Cited by 2 · see citing works

Genetics and biology of pancreatic ductal adenocarcinomaPreprint

Hezel, A. F., Kimmelman, A. C., Stanger, B. Z., Bardeesy, N. M., & DePinho, R. A. (2006) · Genes & Development · doi:10.1101/gad.1415606 · Cited by 1,570 · see citing works

Pancreatic cancer biology and genetics

Bardeesy, N. M., & DePinho, R. A. (2002) · Nature reviews. Cancer · doi:10.1038/nrc949 · Cited by 1,144 · see citing works

Bmi-1 collaborates with c-Myc in tumorigenesis by inhibiting c-Myc-induced apoptosis via INK4a/ARFPreprint

Jacobs, J. J. L., Scheijen, B., Voncken, J. W., Kieboom, K., Berns, A. J. M., & van Lohuizen, M. (1999) · Genes & Development · doi:10.1101/gad.13.20.2678 · Cited by 1,060 · see citing works

Principles of Tumor Suppression

Sherr, C. J. (2004) · Cell · doi:10.1016/s0092-8674(03)01075-4 · Cited by 1,028 · see citing works

Rules for Making Human Tumor Cells

Hahn, W. C., & Weinberg, R. A. (2002) · New England Journal of Medicine · doi:10.1056/nejmra021902 · Cited by 951 · see citing works

Loss of p16Ink4a with retention of p19Arf predisposes mice to tumorigenesis

Sharpless, N. E., Bardeesy, N., Lee, K.-H., Carrasco, D., Castrillon, D. H., Aguirre, A. J., Wu, E. A., Horner, J. W., & DePinho, R. A. (2001) · Nature · doi:10.1038/35092592 · Cited by 848 · see citing works

The MDM2-p53 interaction.

Moll, U. M., & Petrenko, O. (2003) · PubMed · Cited by 778 · see citing works

Ribosome Profiling Provides Evidence that Large Noncoding RNAs Do Not Encode Proteins

Guttman, M., Russell, P., Ingolia, N. T., Weissman, J. S., & Lander, E. S. (2013) · Cell · doi:10.1016/j.cell.2013.06.009 · Cited by 745 · see citing works

Stem Cells and Cancer

Valk-Lingbeek, M. E., Bruggeman, S. W. M., & van Lohuizen, M. (2004) · Cell · doi:10.1016/j.cell.2004.08.005 · Cited by 743 · see citing works

ATM-dependent phosphorylation of Mdm2 on serine 395: role in p53 activation by DNA damage

Maya, R., Balass, M., Kim, S.-T., Shkedy, D., Leal, J.-F. M., Shifman, O., Moas, M., Buschmann, T., Ronai, Z., Shiloh, Y., et al. (2001) · Genes &amp; Development · doi:10.1101/gad.886901 · Cited by 716 · see citing works

BRAF Mutations Are Sufficient to Promote Nevi Formation and Cooperate with p53 in the Genesis of Melanoma

Patton, E. E., Widlund, H. R., Kutok, J. L., Kopani, K. R., Amatruda, J. F., Murphey, R. D., Berghmans, S., Mayhall, E. A., Traver, D. J., Fletcher, C. D. �., et al. (2005) · Current Biology · doi:10.1016/j.cub.2005.01.031 · Cited by 656 · see citing works

The ARF/p53 pathway.

Sherr, C. J., & Weber, J. D. (2000) · Current Opinion in Genetics &amp; Development · doi:10.1016/s0959-437x(99)00038-6 · Cited by 654 · see citing works

Chronic myeloid leukaemia as a model of disease evolution in human cancer

Melo, J. V., & Barnes, D. J. (2007) · Nature reviews. Cancer · doi:10.1038/nrc2147 · Cited by 616 · see citing works

Loss of p16Ink4a confers susceptibility to metastatic melanoma in mice

Krimpenfort, P., Quon, K. C., Mooi, W. J., Loonstra, A., & Berns, A. (2001) · Nature · doi:10.1038/35092584 · Cited by 568 · see citing works

UV-induced DNA damage, repair, mutations and oncogenic pathways in skin cancer

de Gruijl, F. R., van Kranen, H. J., & Mullenders, L. H. F. (2001) · Journal of Photochemistry and Photobiology B Biology · doi:10.1016/s1011-1344(01)00199-3 · Cited by 546 · see citing works

'Super p53' mice exhibit enhanced DNA damage response, are tumor resistant and age normally

García‐Cao, I., García‐Cao, M., Martín‐Caballero, J., Criado, L. M., Klatt, P., Flores, J. M., Weill, J., Blasco, M. A., & Serrano, M. (2002) · The EMBO Journal · doi:10.1093/emboj/cdf595 · Cited by 529 · see citing works

Cancer and ageing: rival demons?

Campisi, J. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1073 · Cited by 512 · see citing works

p16(MTS-1/CDKN2/INK4a) in Cancer Progression

Rocco, J. W., & Sidransky, D. (2001) · Experimental Cell Research · doi:10.1006/excr.2000.5149 · Cited by 464 · see citing works

Nucleolus, Ribosomes, and Cancer

Montanaro, L., Treré, D., & Derenzini, M. (2008) · American Journal Of Pathology · doi:10.2353/ajpath.2008.070752 · Cited by 456 · see citing works

INK4a/ARF: A multifunctional tumor suppressor locus

Sharpless, N. E. (2005) · Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis · doi:10.1016/j.mrfmmm.2004.08.021 · Cited by 442 · see citing works

Bmi1, stem cells, and senescence regulation

Park, I.-K., Morrison, S. J., & Clarke, M. F. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200420800 · Cited by 495 · see citing works

Pancreatic cancer biology and genetics from an evolutionary perspective

Makohon-Moore, A. P., & Iacobuzio–Donahue, C. A. (2016) · Nature reviews. Cancer · doi:10.1038/nrc.2016.66 · Cited by 430 · see citing works

Opposing roles for p16Ink4a and p19Arf in senescence and ageing caused by BubR1 insufficiency

Baker, D. J., Perez-Terzic, C., Jin, F., Pitel, K. S., Niederländer, N. J., Jeganathan, K., Yamada, S., Reyes, S., Rowe, L., Hiddinga, H. J., et al. (2008) · Nature Cell Biology · doi:10.1038/ncb1744 · Cited by 408 · see citing works

The power and the promise of oncogene-induced senescence markers

Collado, M., & Serrano, M. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1884 · Cited by 404 · see citing works

Reactive Oxygen Species in Normal and Tumor Stem Cells

Zhou, D., Shao, L., & Spitz, D. R. (2014) · Advances in cancer research · doi:10.1016/b978-0-12-420117-0.00001-3 · Cited by 400 · see citing works

NUMB controls p53 tumour suppressor activity

Colaluca, I. N., Tosoni, D., Nuciforo, P., Senic-Matuglia, F., Galimberti, V., Viale, G., Pece, S., & Di Fiore, P. P. (2008) · Nature · doi:10.1038/nature06412 · Cited by 385 · see citing works

Cell cycle checkpoints and their inactivation in human cancer

Molinari, M. (2000) · Cell Proliferation · doi:10.1046/j.1365-2184.2000.00191.x · Cited by 389 · see citing works

Alterations of the Notch pathway in lung cancer

Westhoff, B., Colaluca, I. N., D’Ario, G., Donzelli, M., Tosoni, D., Volorio, S., Pelosi, G., Spaggiari, L., Mazzarol, G., Viale, G., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0907781106 · Cited by 388 · see citing works

Translating p53 into the clinic

Cheok, C. F., Verma, C. S., Baselga, J., & Lane, D. P. (2011) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2010.174 · Cited by 381 · see citing works

DAP kinase activates a p19ARF/p53-mediated apoptotic checkpoint to suppress oncogenic transformation

Raveh, T., Droguett, G., Horwitz, M. S., DePinho, R. A., & Kimchi, A. (2001) · Nature Cell Biology · doi:10.1038/35050500 · Cited by 361 · see citing works

Total body irradiation selectively induces murine hematopoietic stem cell senescence.

Wang, Y., Schulte, B. A., LaRue, A. C., Ogawa, M., & Zhou, D. (2006) · Blood · doi:10.1182/blood-2005-04-1418 · Cited by 351 · see citing works

Naive T Cell Maintenance and Function in Human Aging

Goronzy, J. J., Fang, F., Cavanagh, M., Qi, Q., & Weyand, C. M. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1500046 · Cited by 348 · see citing works

Polycomb CBX7 has a unifying role in cellular lifespan.

Gil, J., Bernard, D., Martínez, D., & Beach, D. (2004) · Nature Cell Biology · doi:10.1038/ncb1077 · Cited by 341 · see citing works

Hematopoietic Stem Cell Injury Induced by Ionizing Radiation

Shao, L., Luo, Y., & Zhou, D. (2013) · Antioxidants and Redox Signaling · doi:10.1089/ars.2013.5635 · Cited by 337 · see citing works

A pivotal role for ERK in the oncogenic behaviour of malignant melanoma?

Smalley, K. S. M. (2003) · International Journal of Cancer · doi:10.1002/ijc.10978 · Cited by 320 · see citing works

Cyclin-Dependent Kinase Inhibitors: Useful Targets in Cell Cycle Regulation

Sielecki, T. M., Boylan, J. F., Benfield, P. A., & Trainor, G. L. (2000) · Journal of Medicinal Chemistry · doi:10.1021/jm990256j · Cited by 321 · see citing works

The INK4 family of cell cycle inhibitors in cancer

Roussel, M. F. (1999) · Oncogene · doi:10.1038/sj.onc.1202998 · Cited by 323 · see citing works

<i>Ink4a</i> and <i>Arf</i> differentially affect cell proliferation and neural stem cell self-renewal in <i>Bmi1</i>-deficient mice

Bruggeman, S. W. M., Valk-Lingbeek, M. E., van der Stoop, P. P. M., Jacobs, J. J. L., Kieboom, K., Tanger, E., Hulsman, D., Leung, C., Arsenijevic, Y., Marino, S., et al. (2005) · Genes &amp; Development · doi:10.1101/gad.1299305 · Cited by 315 · see citing works

Senescence bypass screen identifies TBX2, which represses Cdkn2a (p19ARF) and is amplified in a subset of human breast cancers

Jacobs, J. J. L., Keblusek, P., Robanus-Maandag, E., Kristel, P., Lingbeek, M., Nederlof, P. M., van Welsem, T., van de Vijver, M. J., Koh, E. Y., Daley, G. Q., et al. (2000) · Nature Genetics · doi:10.1038/81583 · Cited by 368 · see citing works

Senescent Cells: A Novel Therapeutic Target for Aging and Age-Related Diseases

Naylor, R. M., Baker, D. J., & van Deursen, J. M. (2012) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2012.193 · Cited by 280 · see citing works

Cooperative Signals Governing ARF-Mdm2 Interaction and Nucleolar Localization of the Complex

Weber, J. D., Kuo, M.-L., Bothner, B. B., DiGiammarino, E. L., Kriwacki, R. W., Roussel, M. F., & Sherr, C. J. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.7.2517-2528.2000 · Cited by 273 · see citing works

A critical role for telomeres in suppressing and facilitating carcinogenesis

Artandi, S. E., & DePinho, R. A. (2000) · Current Opinion in Genetics &amp; Development · doi:10.1016/s0959-437x(99)00047-7 · Cited by 318 · see citing works

The INK4a/ARF locus and melanoma

Sharpless, N. E., & Chin, L. (2003) · Oncogene · doi:10.1038/sj.onc.1206461 · Cited by 260 · see citing works

The t(8;21) fusion protein, AML1–ETO, specifically represses the transcription of the p14ARF tumor suppressor in acute myeloid leukemia

Linggi, B. E., Müller‐Tidow, C., van de Locht, L. T., Hu, M., Nip, J., Serve, H. L., Berdel, W. E., van der Reijden, B., Quelle, D. E., Rowley, J. D., et al. (2002) · Nature Medicine · doi:10.1038/nm726 · Cited by 256 · see citing works

Age to survive: DNA damage and aging

Schumacher, B., Garinis, G. A., & Hoeijmakers, J. H. J. (2008) · Trends in Genetics · doi:10.1016/j.tig.2007.11.004 · Cited by 255 · see citing works

Stabilization of p53 by p14ARF without relocation of MDM2 to the nucleolus

Llanos, S., Clark, P. A., Rowe, J., & Peters, G. G. (2001) · Nature Cell Biology · doi:10.1038/35074506 · Cited by 252 · see citing works

Cellular Senescence: Molecular Mechanisms, In Vivo Significance, and Redox Considerations

Müller, M. K. (2008) · Antioxidants and Redox Signaling · doi:10.1089/ars.2008.2104 · Cited by 237 · see citing works

Cell proliferation and apoptosis

Guo, M., & Hay, B. A. (1999) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(99)00046-0 · Cited by 238 · see citing works

Differential impact of Ink4a and Arf on hematopoietic stem cells and their bone marrow microenvironment in Bmi1-deficient mice

Oguro, H., Iwama, A., Morita, Y., Kamijo, T., van Lohuizen, M., & Nakauchi, H. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20052477 · Cited by 227 · see citing works

INK4a‐deficient human diploid fibroblasts are resistant to RAS‐induced senescence

Brookes, S., Rowe, J., Ruas, M., Llanos, S., Clark, P. A., Lomax, M., James, M. C., Vatcheva, R., Bates, S., Vousden, K. H., et al. (2002) · The EMBO Journal · doi:10.1093/emboj/cdf289 · Cited by 220 · see citing works

Role of p14^ARF in Replicative and Induced Senescence of Human Fibroblasts

Wei, W., Hemmer, R. M., & Sedivy, J. M. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.20.6748-6757.2001 · Cited by 217 · see citing works

Limited regeneration in long acellular nerve allografts is associated with increased Schwann cell senescence

Saheb-Al-Zamani, M., Yan, Y., Farber, S. J., Hunter, D. A., Newton, P., Wood, M. D., Stewart, S. A., Johnson, P. J., & Mackinnon, S. E. (2013) · Experimental Neurology · doi:10.1016/j.expneurol.2013.04.011 · Cited by 212 · see citing works

Cancer Therapy-Induced Residual Bone Marrow Injury: Mechanisms of Induction and Implication for Therapy

Wang, Y., Probin, V., & Zhou, D. (2006) · Current Cancer Therapy Reviews · doi:10.2174/157339406777934717 · Cited by 214 · see citing works

Translational Repression of C. elegans p53 by GLD-1 Regulates DNA Damage-Induced Apoptosis

Schumacher, B., Hanazawa, M., Lee, M., Nayak, S., Volkmann, K., Hofmann, R., Hengartner, M. O., Schedl, T., & Gartner, A. (2005) · Cell · doi:10.1016/j.cell.2004.12.009 · Cited by 214 · see citing works

Human melanocyte senescence and melanoma susceptibility genes

Bennett, D. C. (2003) · Oncogene · doi:10.1038/sj.onc.1206446 · Cited by 210 · see citing works

Bmi1 Is a Key Epigenetic Barrier to Direct Cardiac Reprogramming

Zhou, Y., Wang, L., Vaseghi, H. R., Liu, Z., Lu, R., Alimohamadi, S., Yin, C., Fu, J., Wang, G. G., Liu, J., et al. (2016) · Cell stem cell · doi:10.1016/j.stem.2016.02.003 · Cited by 211 · see citing works

Wide spectrum of tumors in knock‐in mice carrying a Cdk4 protein insensitive to INK4 inhibitors

Sotillo, R., Dubus, P., Martn, J., de la Cueva, E., Ortega, S., Malumbres, M., & Barbacid, M. (2001) · The EMBO Journal · doi:10.1093/emboj/20.23.6637 · Cited by 208 · see citing works

Resveratrol ameliorates ionizing irradiation-induced long-term hematopoietic stem cell injury in mice

Zhang, H., Zhai, Z., Wang, Y., Zhang, J., Wu, H., Wang, Y., Li, C., Li, D., Lu, L., Wang, X., et al. (2012) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2012.10.530 · Cited by 207 · see citing works

Deregulated β‐catenin induces a p53‐ and ARF‐dependent growth arrest and cooperates with Ras in transformation

Damalas, A., Kahan, S., Shtutman, M. S., Ben‐Ze'ev, A., & Oren, M. (2001) · The EMBO Journal · doi:10.1093/emboj/20.17.4912 · Cited by 206 · see citing works

DNA methylation in breast cancer.

Yang, X., Yan, L., & Davidson, N. E. (2001) · Endocrine Related Cancer · doi:10.1677/erc.0.0080115 · Cited by 205 · see citing works

RB1 in cancer: Different mechanisms of RB1 inactivation and alterations of pRb pathway in tumorigenesis

Fiore, R. D., D’Anneo, A., Tesoriere, G., & Vento, R. (2013) · Journal of Cellular Physiology · doi:10.1002/jcp.24329 · Cited by 201 · see citing works

Reactive oxygen species and hematopoietic stem cell senescence

Shao, L., Li, H., Pazhanisamy, S. K., Meng, A., Wang, Y., & Zhou, D. (2011) · International Journal of Hematology · doi:10.1007/s12185-011-0872-1 · Cited by 198 · see citing works

DNA methylation in hepatocellular carcinoma

Tischoff, I. (2008) · World Journal of Gastroenterology · doi:10.3748/wjg.14.1741 · Cited by 193 · see citing works

Ionizing radiation and busulfan induce premature senescence in murine bone marrow hematopoietic cells.

Meng, A., Wang, Y., Zant, G. E. V., & Zhou, D. (2003) · PubMed · Cited by 193 · see citing works

WormBook

Gartner, A., Boag, P. R., & Blackwell, T. K. (2008) · WormBook · doi:10.1895/wormbook.1.145.1 · Cited by 192 · see citing works

The epistemic goal of a concept: accounting for the rationality of semantic change and variation

Brigandt, I. (2009) · Synthese · doi:10.1007/s11229-009-9623-8 · Cited by 189 · see citing works

Transient Inactivation of Rb and ARF Yields Regenerative Cells from Postmitotic Mammalian Muscle

Pajcini, K. V., Corbel, S. Y., Sage, J., Pomerantz, J. H., & Blau, H. M. (2010) · Cell stem cell · doi:10.1016/j.stem.2010.05.022 · Cited by 188 · see citing works

Molecular markers in oral epithelial dysplasia: review

Pitiyage, G. N., Tilakaratne, W. M., Tavassoli, M., & Warnakulasuriya, S. (2009) · Journal of Oral Pathology and Medicine · doi:10.1111/j.1600-0714.2009.00804.x · Cited by 185 · see citing works

p16Ink4a in Melanocyte Senescence and Differentiation

Sviderskaya, E. V. (2002) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/94.6.446 · Cited by 177 · see citing works

Control of p53 ubiquitination and nuclear export by MDM2 and ARF.

Zhang, Y., & Xiong, Y. (2001) · PubMed · Cited by 176 · see citing works

Epigenetic Control of a Transcription Factor at the Cross Section of Two Antagonistic Pathways

Álvarez-Venegas, R., Al-Abdallat, A. M., Guo, M., Alfano, J. R., & AVRAMOVA, Z. V. (2007) · Epigenetics · doi:10.4161/epi.2.2.4404 · Cited by 171 · see citing works

The human cytochrome P450 3A locus. Gene evolution by capture of downstream exons

Finta, C., & Zaphiropoulos, P. G. (2000) · Gene · doi:10.1016/s0378-1119(00)00470-4 · Cited by 170 · see citing works

p19ARF targets certain E2F species for degradation

Martelli, F., Hamilton, T., Silver, D. P., Sharpless, N. E., Bardeesy, N. M., Rokas, M., DePinho, R. A., Livingston, D. M., & Grossman, S. R. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.081061398 · Cited by 167 · see citing works

Total body irradiation causes long-term mouse BM injury via induction of HSC premature senescence in an Ink4a- and Arf-independent manner

Shao, L., Feng, W., Li, H., Gardner, D., Luo, Y., Wang, Y., Liu, L., Meng, A., Sharpless, N. E., & Zhou, D. (2014) · Blood · doi:10.1182/blood-2013-07-515619 · Cited by 165 · see citing works

Genetically defined mouse models that mimic natural aspects of human prostate cancer development.

Roy‐Burman, P., Wu, H., Powell, W. C., Hagenkord, J. M., & Cohen, M. B. (2004) · Endocrine Related Cancer · doi:10.1677/erc.0.0110225 · Cited by 164 · see citing works

Dual Inactivation of RB and p53 Pathways in RAS-Induced Melanomas

Bardeesy, N., Bastian, B. C., Hezel, A., Pinkel, D., DePinho, R. A., & Chin, L. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.6.2144-2153.2001 · Cited by 166 · see citing works

Invasive melanoma in Cdk4-targeted mice

Sotillo, R., García, J. F., Ortega, S., Martín‐Broto, J., Dubus, P. R., Barbacid, M., & Malumbres, M. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.241338598 · Cited by 164 · see citing works

NF‐κB activation in melanoma

Ueda, Y., & Richmond, A. (2006) · Pigment Cell Research · doi:10.1111/j.1600-0749.2006.00304.x · Cited by 148 · see citing works

Constitutive and inducible expression and regulation of vascular endothelial growth factor

Xie, K., Wei, D., Shi, Q., & Huang, S. (2004) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2004.04.003 · Cited by 163 · see citing works

The Arabidopsis homolog of trithorax, ATX1, binds phosphatidylinositol 5-phosphate, and the two regulate a common set of target genes

Álvarez-Venegas, R., Sadder, M. T., Hlavačka, A., Baluška, F., Xia, Y., Lu, G., Firsov, A., Sarath, G., Moriyama, H., DUBROVSKY, J. G., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0600944103 · Cited by 161 · see citing works

PPARα inhibits vascular smooth muscle cell proliferation underlying intimal hyperplasia by inducing the tumor suppressor p16INK4a

Gizard, F., Amant, C., Barbier, O., Bellosta, S., Robillard, R., Percevault, F., Sevestre, H., Krimpenfort, P., Corsini, A., Rochette, J., et al. (2005) · Journal of Clinical Investigation · doi:10.1172/jci22756 · Cited by 159 · see citing works

Suppression of p53 by Notch in lymphomagenesis: implications for initiation and regression

Beverly, L. J., Felsher, D. W., & Capobianco, A. J. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1664 · Cited by 157 · see citing works

Cellular Response to Oncogenic Ras Involves Induction of the Cdk4 and Cdk6 Inhibitor p15INK4b

Malumbres, M., de Castro, I. P., Hernández, M. I., Jiménez, M., Corral, T., & Pellicer, À. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.8.2915-2925.2000 · Cited by 154 · see citing works

Resveratrol causes arrest in the S-phase prior to Fas-independent apoptosis in CEM-C7H2 acute leukemia cells

Bernhard, D., Tinhofer, I., Tonko, M., Hübl, H., Ausserlechner, M., Greil, R., Kofler, R., & Csordas, A. (2000) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4400719 · Cited by 156 · see citing works

Role of Polycomb Group Proteins in Stem Cell Self-Renewal and Cancer

Gil, J., Bernard, D., & Peters, G. G. (2005) · DNA and Cell Biology · doi:10.1089/dna.2005.24.117 · Cited by 152 · see citing works

p 21WAF1 C ontrol of E pithelial C ell C ycle and C ell F ate

Weinberg, W. C., & Denning, M. F. (2002) · Critical Reviews in Oral Biology & Medicine · doi:10.1177/154411130201300603 · Cited by 150 · see citing works

Promoter hypermethylation: a common cause of reduced p16(INK4a) expression in uveal melanoma.

van der Velden, P. A., Metzelaar-Blok, J. A. W., Bergman, W., Monique, H., Hurks, H. M. H., Frants, R. R., Gruis, N. A., & Jager, M. J. (2001) · PubMed · Cited by 147 · see citing works

A novel anticancer agent, icaritin, induced cell growth inhibition, G1 arrest and mitochondrial transmembrane potential drop in human prostate carcinoma PC-3 cells

Huang, X. Y., Zhu, D., & Lou, Y. (2007) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2007.02.039 · Cited by 146 · see citing works

Genetic analysis of Pten and Ink4a/Arf interactions in the suppression of tumorigenesis in mice

You, M. J., Castrillón, D. H., Bastian, B. C., O’Hagan, R. C., Bosenberg, M., Parsons, R. E., Chin, L., & DePinho, R. A. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.022632099 · Cited by 144 · see citing works

Contribution of p16 ^<i>INK4a</i> and p21 ^<i>CIP1</i> pathways to induction of premature senescence of human endothelial cells: permissive role of p53

Chen, J., Huang, X., Halicka, D., Brodsky, S., Avram, A., Eskander, J., Bloomgarden, N. A., Darzynkiewicz, Z., & Goligorsky, M. S. (2006) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00364.2005 · Cited by 142 · see citing works

Alterations of p16(INK4a) and p14(ARF) in patients with severe oral epithelial dysplasia.

Kresty, L. A., Mallery, S. R., Knobloch, T. J., Song, H., Lloyd, M., Casto, B. C., & Weghorst, C. M. (2002) · PubMed · Cited by 142 · see citing works

Cdk4 disruption renders primary mouse cells resistant to oncogenic transformation, leading to Arf/p53-independent senescencePreprint

Zou, X., Ray, D., Aziyu, A., Christov, K. T., Boiko, A. D., Gudkov, A. V., & Kiyokawa, H. (2002) · Genes & Development · doi:10.1101/gad.1033002 · Cited by 143 · see citing works

The T-box Repressors TBX2 and TBX3Specifically Regulate the Tumor Suppressor Genep14 via a Variant T-site in the Initiator

Lingbeek, M. E., Jacobs, J. J. L., & van Lohuizen, M. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200403200 · Cited by 160 · see citing works

The p16INK4A tumor suppressor regulates cellular oxidative stress

Jenkins, N. C., Liu, T., Cassidy, P., Leachman, S. A., Boucher, K. M., Goodson, A. G., Samadashwily, G., & Grossman, D. (2011) · Oncogene · doi:10.1038/onc.2010.419 · Cited by 138 · see citing works

Bi-allelic Loss of CDKN2A Initiates Melanoma Invasion via BRN2 Activation

Zeng, H., Jorapur, A., Shain, A. H., Lang, U. E., Torres, R., Zhang, Y., McNeal, A. S., Botton, T., Lin, J., Donne, M. L., et al. (2018) · Cancer Cell · doi:10.1016/j.ccell.2018.05.014 · Cited by 138 · see citing works

The nucleolus: a central response hub for the stressors that drive cancer progression

Weeks, S. E., Metge, B. J., & Samant, R. S. (2019) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-019-03231-0 · Cited by 112 · see citing works

Targeting Cardiac Stem Cell Senescence to Treat Cardiac Aging and Disease

Cianflone, E., Torella, M., Biamonte, F., Angelis, A. D., Urbanek, K., Costanzo, F. S., Rota, M., Ellison, G. M., & Torella, D. (2020) · Cells · doi:10.3390/cells9061558 · Cited by 134 · see citing works

p14ARF silencing by promoter hypermethylation mediates abnormal intracellular localization of MDM2.

Esteller, M., Cordon‐Cardo, C., Corn, P. G., Meltzer, S. J., Pohar, K. S., Watkins, D. N., Capellá, G., Peinado, M. A., Matías‐Guiu, X., Prat, J., et al. (2001) · PubMed · Cited by 132 · see citing works

Androgen receptor-dependent and -independent mechanisms driving prostate cancer progression: Opportunities for therapeutic targeting from multiple angles

Hoang, D. T., Iczkowski, K. A., Kilari, D., See, W. A., & Nevalainen, M. T. (2016) · Oncotarget · doi:10.18632/oncotarget.12554 · Cited by 128 · see citing works

Review: IRF-1 as a Negative Regulator of Cell Proliferation

Romeo, G., Fiorucci, G., Chiantore, M. V., Percario, Z. A., Vannucchi, S., & Affabris, E. (2002) · Journal of Interferon & Cytokine Research · doi:10.1089/107999002753452647 · Cited by 123 · see citing works

INK4a/ARF

(2006) · Springer eBooks · doi:10.1007/3-540-29623-9_7504

The INK4A/ARF Locus: Role in Cell Cycle Control and Apoptosis and Implications for Glioma Growth

Ivanchuk, S. M., Mondal, S., Dirks, P. B., & Rutka, J. T. (2001) · Journal of Neuro-Oncology · doi:10.1023/a:1010632309113 · Cited by 80 · see citing works

The INK4a/ARF Locus

Quelle, D. E., Nteeba, J., & Darbro, B. W. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-394447-4.30060-8 · Cited by 4 · see citing works

The INK4α/ARF Locus

Quelle, D. E., Nteeba, J., & Darbro, B. W. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-821618-7.30060-8

The INK4A Locus and the p16 INK4A and p19 ARF Genes

Park, B. H., & Vogelstein, B. (2003)